Monitoring of Mycophenolic Acid Concentration for Mycophenolate Mofetil Treatment in Patients with Glomerular Diseases

ZHENG Chunxia,LIU Zhihong,QIN Weisong,ZENG Caihong,LI Leishi

DOI: https://doi.org/10.3969/j.issn.1006-298x.2007.05.002

2007-01-01

Abstract:Objective:To monitor mycophenolic acid(MPA)concentration in patients with glomerular diseases who were treated by mycophenolate mofetil(MMF)and to analyze the relationships of MMF dose-MPA concentration-side effects and influence factors on MPA concentration.Methodology:One hundred-ten Chinese patients with biopsy-proven glomerular diseases,including lupus nephritis(n=73),IgA nephritis(n=21)and systemic vasculitis(n=16)were enrolled into this study.MMF was taken in oral dose of 1.5(n=74)or 2.0 g/d(n=36),and plasma MPA concentration was measured by HPLC.MPA concentration was given by the area under concentration-time curve from 0 to 12 hours(AUC0-12h)which was calculated by C0,C0.5h and C2h.Results:Mean of MPA concentration was(44.9±12.9)mg·h/L in patients with 1.5 g/d MMF and(51.29±15.12)mg·h/L with 2.0 g/d MMF.MPA concentration in 2.0 g/d MMF group was significantly higher than that in 1.5 g/d MMF group(P0.05).The patients who could reach effectively therapeutic MPA concentration range(30～60 mg·h/L)were 78.4% in 1.5 g/d MMF group and 72.2% in 2.0 g/d MMF group.In comparison with 2.0 g/d MMF group,the percent of MPA concentration 30 mg×h/L in 1.5 g/d MMF group was significantly lower(P0.05),and 60 mg·h/L significantly lower(P0.05).There was no significance rate of side effects between 2.0 g/d MMF and 1.5 g/d MMF,but 2.0 g/d MMF had an increasing tendency compared with 1.5 g/d MMF(P0.05).In the both groups,MPA concentration was remarkably positively correlated with albumin and serum creatinine(P0.01 and P0.05),negatively with body weight(P0.01 and P0.05),whereas no correlation with gender and age.Conclusion:In patients with glomerular diseases who were treated by a dose of 1.5 or 2.0 g/d MMF,MPA concentration of over 70% was within the range of 30～60 mg·h/L.However,in the patients with 2.0 g/d MMF,the percent of 60 mg·h/L is significantly higher than that 1.5 g/d MMF.Additionally,the patients with 2.0 g/d MMF has a tendency of increasing risk of side effects compared with 1.5 g/d MMF.MPA concentration is significantly influenced by body weight,albumin and serum creatinine.Clinically,it is necessary to regulate MMF dose according to therapeutic effects and side effects combining with the impact factors and MPA concentration,aiming at getting maximal therapeutic efficacy and minimal side effects.